Maud de Klerk-Starmans

Citado por

	Total	Desde 2020
Citas	2581	1056
Índice h	21	14
Índice i10	28	17

300

150

225

2008200920102011201220132014201520162017201820192020202120222023202420258 9 12 41 38 52 123 169 210 299 274 254 235 251 203 174 174 19

Acceso público

Ver todo

25 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBDirección de correo verificada de maastrichtuniversity.nl
Paul C. BoutrosUniversity of California, Los AngelesDirección de correo verificada de mednet.ucla.edu
Bradly WoutersPrincess Margaret Cancer Centre, University Health Network, University of TorontoDirección de correo verificada de uhn.ca
Syed HaiderThe Institute of Cancer Research, LondonDirección de correo verificada de icr.ac.uk
Renaud SeigneuricAssociate ProfessorDirección de correo verificada de u-bourgogne.fr
Thomas JohnMedical Oncologist, Peter MacCallum Cancer CentreDirección de correo verificada de petermac.org
Ludwig DuboisMaastricht UniversityDirección de correo verificada de maastrichtuniversity.nl
Francesca BuffaProfessor Computing Sciences @Bocconi University - CBIG Lab @Oxford University - AI Lab @IFOM MilanDirección de correo verificada de unibocconi.it
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityDirección de correo verificada de oncology.ox.ac.uk
Ruud G.P.M. van StiphoutPrincipal Data Scientist at imec within OnePlanet Research CenterDirección de correo verificada de imec.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Dirección de correo verificada de maastro.nl
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUDirección de correo verificada de dfci.harvard.edu
Marianne KoritzinskyUniversity of TorontoDirección de correo verificada de uhnresearch.ca
Balaji KrishnapuramIBM Watson HealthDirección de correo verificada de us.ibm.com
Ming TsaoUniversity of Toronto, University Health Network, Princess Margaret Cancer CentreDirección de correo verificada de uhn.ca
Wouter van ElmptMaastricht University Medical CentreDirección de correo verificada de maastro.nl
Cary OberijeDirección de correo verificada de maastrichtuniversity.nl
Erik RoelofsMAASTRO Clinic, Maastricht University, GROWDirección de correo verificada de maastro.nl
Georgi NalbantovManaging Director, Data Science Consulting Ltd.; Research Fellow at FEBA, Sofia UniversityDirección de correo verificada de childish.ai
Glenn FungElevance HealthDirección de correo verificada de elevancehealth.com

Seguir

Maud de Klerk-Starmans

VieCuri Medical Center

Dirección de correo verificada de viecuri.nl

Medical informatics Data science Decision Support Care Pathways


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015	561	2015
Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27-40, 2013	461	2013
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 5203, 2014	247	2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 5203, 2014	247	2014
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ... Mutation Research/Reviews in Mutation Research 764, 16-30, 2015	221	2015
BPG: Seamless, automated and interactive visualization of scientific data C P’ng, J Green, LC Chong, D Waggott, SD Prokopec, M Shamsi, ... BMC bioinformatics 20, 1-5, 2019	107	2019
Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ... International Journal of Cancer 140 (3), 662-673, 2017	98	2017
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung … P Lambin, SF Petit, HJWL Aerts, WJC van Elmpt, CJG Oberije, ... Radiotherapy and oncology 96 (2), 145-152, 2010	92	2010
Impact of supervised gene signatures of early hypoxia on patient survival R Seigneuric, MHW Starmans, G Fung, B Krishnapuram, DSA Nuyten, ... Radiotherapy and oncology 83 (3), 374-382, 2007	84	2007
Epigenetics in radiotherapy: Where are we heading? KM Smits, V Melotte, HEC Niessen, L Dubois, C Oberije, EGC Troost, ... Radiotherapy and Oncology 111 (2), 168-177, 2014	64	2014
The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia MBE Schaaf, D Cojocari, TG Keulers, B Jutten, MH Starmans, MC de Jong, ... Radiotherapy and Oncology 108 (3), 529-534, 2013	61	2013
A pilot study comparing HPV‐positive and HPV‐negative head and neck squamous cell carcinomas by whole exome sequencing AC Nichols, M Chan-Seng-Yue, J Yoo, W Xu, S Dhaliwal, J Basmaji, ... International Scholarly Research Notices 2012 (1), 809370, 2012	56	2012
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types MHW Starmans, B Krishnapuram, H Steck, H Horlings, DSA Nuyten, ... British journal of cancer 99 (11), 1884-1890, 2008	55	2008
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ... Radiotherapy and Oncology 102 (3), 436-443, 2012	54	2012
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer medicine 2 (6), 916-924, 2013	51	2013
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer Medicine 2 (6), 916-924, 2013	51	2013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer T John, MHW Starmans, YT Chen, PA Russell, SA Barnett, SC White, ... PloS one 8 (7), e67876, 2013	48	2013
Pathway-based subnetworks enable cross-disease biomarker discovery S Haider, CQ Yao, VS Sabine, M Grzadkowski, V Stimper, MHW Starmans, ... Nature communications 9 (1), 4746, 2018	35	2018
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences NS Fox, MHW Starmans, S Haider, P Lambin, PC Boutros BMC bioinformatics 15, 1-14, 2014	34	2014
Systematic analysis of ¹⁸F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors BAW Hoeben, MHW Starmans, RTH Leijenaar, LJ Dubois, ... BMC cancer 14, 1-12, 2014	28	2014

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores